 0%, 44.9%, 35.7%, 33.1% and 27.6% and 74.5%, 55.2%, 44.8%, 43.0%, and 37.6%, respectively. Cumulative limb salvage was 86.4%, 78.7%, and 73.2% at 1, 3, and 5 years, respectively. 
Introduction
the development of myointimal hyperplasia (MIH) a new type of distal end-to-side anastomosis was developed by Scholz in 1992. This, characterised by a Arterial bypass to restore flow to a patent distal artery bifurcated double bulb, 14,15 is termed femorocrural has been established as the most appropriate treatment patch prosthesis (FCPP). In vitro flow visualisation of lower extremity occlusive arterial disease. Although experiments using dye distribution techniques and the greater saphenous vein represents the conduit of colour-coded Doppler sonography and numerical simchoice for infrainguinal femorodistal bypass proulation of the complex flow field have demonstrated cedures, 1 there remains a significant percentage of improved haemodynamics within the FCPP compared patients who lack autologous vein of adequate length to other types of end-to-side anastomosis. 15 In paror quality. [2] [3] [4] In the absence of adequate autologous ticular, the flow phenomena associated with the devein, expanded polytetrafluoroethylene (ePTFE) has velopment of MIH could be minimised or even were been established as an alternative bypass graft maeliminated within the FCPP. terial. [5] [6] [7] [8] The patency rates of heterologous grafts, howThe purpose of the present study was to evaluate ever, are clearly inferior to autologous vein grafts. 6, 8, 9 the feasibility, clinical and haemodynamic results asSeveral methods have been described to improve the sociated with the use of the FCPP. patency of below-knee ePTFE arterial grafts including venous cuff techniques 10-12 and arteriovenous fistula.
or severe ischaemia and who required infragenicular bypass surgery and in whom no greater or lesser saphenous vein was available, were eligible. Age, sex, and the co-morbidity and risk factors were recorded. Usable autologous vein was defined by duplex ultrasound and/or surgical explantation as a greater or lesser saphenous vein that had a diameter of greater than 3 mm after dilatation and one that permitted passage of a catheter through the entire lumen. Patients underwent preoperative non-invasive testing and digital subtraction angiography (DSA) prior to surgery whenever possible. DNA studies were used to assess the runoff status, including the number of patent crural Primary patency was defined as continuous graft and conversion of an end-to-side into two end-to-end anastomoses. patency, uninterrupted by any intervention on the graft. Secondary patency was defined as patency up (Fig. 2a) , proceeding first on the superior edge of the to the time of final graft closure and included the arteriotomy towards the proximal apex and around it results of reintervention for thrombosed or failing to the inferior edge (Fig. 2b) . Thus the length of the grafts. Limb salvage was defined as the preservation arteriotomy could be exactly adapted to the size of of a viable limb with a functional portion of the foot. the patch. Once the proximal segment of the FCPP Patients were anticoagulated postoperatively and anastomosis had been sutured into place, the distal reviewed at 1 month and 3 months after re-part was created, again adapting the arteriotomy to vascularisation, and at 6-month intervals thereafter. the distal part of the patch (Fig. 2c) analogous to the Patency was confirmed by the presence of distal pulses, proximal segment. Suturing was continued on the a persistent rise in ankle-brachial pressure index superior edge first and then around the distal apex to (>0.15), duplex ultrasonography or DSA. For occlusive be completed on the inferior edge until the two sepinflow lesions or progression of distal atherosclerotic arate sutures met, when they were tied together (Fig. disease, adequate surgical intervention was performed 2d). including a proximal extension if required. Any acute thrombotic graft occlusion was managed by thrombectomy using the Fogarty manoeuvre.
Statistical analysis

Surgical technique
Statistical analysis of primary (PPR) and secondary patency rates (SPR) as well as limb salvage and patient The 5 mm diameter, thin-walled and externally sup-survival rates over the time was performed using the ported ePTFE grafts (Impra/C.R. Bard Inc., Tempe, product-limit method according to Kaplan-Meier with AZ, U.S.A.) were positioned extra-anatomically with the S-PLUS 4.5 software package (Professional Rel. 2, the newly designed distal end-to-side anastomosis MathSoft, Inc., Cambridge, MA, U.S.A.). 16 being constructed entirely from ePTFE (beginning with patient no. 44, proximally tapered, 8/5 mm grafts were used). Bypasses originated from the external iliac, the common or the proximal superficial femoral artery.
Results The technique of performing the FCPP anastomosis is illustrated in Figs 1 and 2. About 6 cm length of Between June 1992 and July 1998, 129 patients undergoing 135 bypass procedures were studied. Six patients ePTFE graft was removed and the external spiral stent denuded. This piece was then sutured end-to-side to received a second graft, four because of definite graft occlusion and two because of graft infection. Median the remaining graft to form a patch. Next, the patch was sutured under magnification with continuous Prolene follow-up was 45 (range 6-72) months.
There were 89 men and 40 women with a mean age (6/0 for popliteal, 7/0 for tibial or peroneal) to the recipient artery. The suture line was secured with a of 65.2±10.0 years. At the time of operation, 44% of patients had diabetes, 72% had medically controlled knot in the middle between the bulbs on each side . Schematic representation of the surgical technique to perform the distal FCPP anastomosis. The ePTFE prosthesis is prepared at its distal end by suturing it to a patch, also made from ePTFE, which is especially configured as a double bulb. The suture line starts from the centre of the posterior wall (a) and runs first to the proximal corner and thereafter back to the centre of the anterior wall (b). A second running suture is performed to create the distal part of the FCPP anastomosis (c), with the two sutures meeting to be tied on the anterior wall (d).
hypertension, 22.5% had had myocardial infarction, 64% had a history of smoking, and 9% had renal insufficiency on haemodialysis. Indications for operation were ulcer or gangrene in 70 cases (52%) and rest pain in 65 cases (48%).
In 95 limbs (70%) at least one previous infrainguinal bypass operation had failed. There were 19 grafts (14%) with a zero-vessel run-off and 38 grafts (28%) with a one-vessel run-off. Seventy-eight grafts (58%) had a two-or three-vessel run-off. The plantar arch was incomplete in 71 grafts (52%) and occluded in 24 grafts (18%). There was no perioperative mortality. The cumulative survival at 1, 3, and 5 years was 86.7%, 74.1%, and 68.9%, respectively (Fig. 3) . each point represents the number of patients at risk and the number Thrombectomy was successful in 22 patients. Early of censored events, respectively. occlusion was followed by limb loss in three patients. Another 20 grafts occluded within the first year, all of between two and maximally eight times each. The duration of patency was thereby prolonged in 43 grafts, which were re-explored with restoration of patency. Thrombectomy was required during the postoperative 11 of which remained permanently patent.
PPR and SPR at 1, 2, 3, 4, and 5 years were 63.0%, course in altogether 58 grafts, sometimes repeatedly, 44.9%, 35.7%, 33.1% and 27.6% and 74.5%, 55.2%, 44.8%, 43.0%, and 37.6%, respectively (Fig. 4a,b) . Recipient arteries were below-knee popliteal (21), anterior (46) and posterior (52) tibial, and peroneal (16) (Fig.  5 ). There was no significant difference in PPR or SPR between the recipient arteries (log-rank test). The cumulative limb salvage was 86.4%, 78.7%, and 73.2% at 1, 3, and 5 years, respectively (Fig. 6) .
Graft infection occurred in seven patients (5.2%) requiring explantation of the prosthetic graft in five cases after 1, 6, 9, 14, and 36 months. Re-grafting was later performed successfully in 2 patients. Major amputation was required after graft explantation in 3 patients.
Discussion
Autologous vein remains the conduit of choice for distal revascularisation. 1 However, in up to 28% of patients, vein may be unavailable due to previous coronary artery bypass surgery, varicose-vein stripping, previous infrainguinal revascularisations, insufficient calibre, or as a result of previous episodes of thrombophlebitis. 4 ePTFE-vein composite grafts have been shown to be a valuable alternative to allautologous infragenicular reconstructions. 17 In those patients in whom no saphenous vein is available, arm veins, spliced veins, superficial femoral vein, cryopreserved saphenous vein, and human umbilical vein have been used with varying degrees of success.
18-22
However, when no venous conduit is available heterologous graft materials are required, of which ePTFE has been most commonly used. Long-term results of this prosthetic conduit when used entirely for infra- artery below the knee. 31 Favourable results for vein cuffs in femorodistal ePTFE grafts were also demonstrated in retrospective studies.
32
The vein cuff is believed to eliminate or at least diminish the compliance mismatch between a rigid graft and a small-calibre, more compliant recipient artery. However, the scientific evidence to support this hypothesis is lacking. Sottiurai et al. 33 concluded from experimental work that improvement of compliance mismatch with distal vein patch angioplasty did not prevent MIH formation within the anastomotic site but seemed to reduce the extent of MIH in the more endothelial and smooth muscle cells MIH cannot develop. On the other hand, haemodynamics within the of ePTFE tibial grafts, most of them reporting PPR anastomotic site have been shown to determine the and SPR of 25% or less. [7] [8] [9] 23 Better results have been development and location of MIH, which, in turn, are reported by Christenson et al. 24 with 4-and 6-year related to its geometric configuration. cumulative patency rates of 47% and 43%, respectively, This is the first prospective clinical investigation of for below-knee and 49% for crural distal anastomosis. the FCPP. The elimination of the stagnation point at the Parsons et al. 5 reported 5-year PPR and SPR of 28% floor opposite to the graft entrance may be another and 43%, respectively. In the present series there was important feature of the FCPP anastomosis, as flow a high early occlusion rate of 20%. However, the stagnation coincides with a high-pressure zone within angiographic run-off status as a rough measure of the anastomotic site, and the development of MIH. The outflow resistance characterised the patients in this FCPP anastomosis strongly resembles two end-to-end series as mostly poor-risk candidates. 7, 24, 25 anastomoses each with the proximal and distal recipient Caution should be used in interpreting the results of artery, thus possibly avoiding the basic haemodynamic the present study for several reasons. The rather high disadvantages of end-to-side anastomoses. percentage of secondary procedures in the present series Da Silva et al. 34 showed that stable vortices within reflects a non-selected poor prognosis patient popuvein cuffs inhibit anastomotic MIH. Based on these lation. 7 In particular, occlusion of the pedal arch artery observations, another new ePTFE graft design to inand all three crural arteries was not a contraindication hibit MIH in small-vessel anastomoses was proposed. 35 to grafting with distal FCPP anastomosis. In this study, This development resulted in the Distaflo bypass graft we did not attempt to diminish outflow resistance by now available, in which the distal end has the shape creating an arteriovenous fistula. In a recent study, of a Miller cuff (Distaflo, Impra/C.R.Bard Inc., Tempe, Hamsho et al. have shown that an adjuvant arterio-AZ, U.S.A.). Compared with the FCPP, the design of venous fistula confers no additional significant clinical this graft represents a different way of dealing with advantage over interposition vein cuff alone. 26 MIH at the distal end-to-side anastomosis of ePTFE MIH at the distal anastomosis remains a major cause grafts. The Distaflo design differs from our new anaof failure in ePTFE bypass grafts to the below-knee stomosis, because detailed analyses of the complex and crural level. 25, [27] [28] [29] flow field demonstrated only minimal vortex for-A vein cuff was originally suggested as a method mation in the heel and virtually none in the toe region of anastomosing mismatched Dacron grafts to smaller of the FCPP anastomosis. However, both the FCPP arteries. 30 The modification of a vein cuff reported by anastomotic design and the Distaflo prosthesis with Taylor et al. 11 was shown to achieve high success rates its pre-shaped distal anastomosis represent alternative with a 5-year PPR of 54% in a series of 83 tibioperoneal solutions of anastomotic engineering to overcome ePTFE bypass grafts. In a multicentre randomised MIH. Although there are differences between the prospective study, using a distal anastomosis inshapes and the flow structures generated, both grafts terposition vein cuff as described by Miller et al., 10 aim to minimise anastomotic MIH by eliminating areas there was a statistically significant advantage when PTFE bypass grafts were anastomosed to the popliteal of low shear stress. 
